# Bortezomib

NDC: 70511-161
Generic name: bortezomib
Labeler / Manufacturer: MAIA Pharmaceuticals, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION
Routes: INTRAVENOUS
Marketing started: 20220811

FDA application: NDA215331

## Active ingredients

- BORTEZOMIB: 1 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"70511-161"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=70511-161
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c40e6a28-d577-43d4-bca6-bef28da1d580